relevant depressive symptoms (CRDS, defined by a BDIscore ≥ 18) the self-reporting Beck Depression Inventory (BDI) was obtained on inclusion in the study. Associations with baseline parameters, stroke severity (National Institutes of Health Stroke Scale, NIHSS), and brain MRI findings were analyzed. Results: From the 2007 patients with BDI documentation, 202 (10.1%) had CRDS. CRDS were observed more frequently in women (12.6 vs. 8.2% in men, p < 0.001). Patients with CRDS more often had arterial hypertension, diabetes mellitus, and hyperlipidemia than patients without CRDS (hypertension: 58.0 vs. 47.1%, p = 0.017; diabetes mel-
Introduction
As a disabling disease, stroke has an enormous emotional impact [1, 2] . In this context, depression is an important consequence, which influences stroke recovery [1, [3] [4] [5] . Most of the studies on mood disorders were conducted in general stroke populations without focusing on young patients, although in those, depression is particularly relevant with impact on the social and occupational re-integration [5, 6] . Recently, several studies on young stroke provided important information on age and gender distribution, risk factors, etiologic factors, and imaging findings [7, 8] . However, data on mood disorders such as depression in this specific group are limited. Investigating the occurrence, distribution, clinical and imaging correlates of depressive symptoms in young stroke patients is important, as depression has severe consequences in terms of its impact on stroke recovery.
We therefore investigated depressive symptoms and potential determinants in acute young stroke patients included in the Stroke in Young Fabry Patients study (sifap1), a large multicentre European study on young stroke [8] .
Methods

Design of the Study
The multinational sifap1 study (47 centers in 15 European countries) prospectively recruited (between April 2007 and January 2010) 5,023 patients aged 18-55 with a cerebrovascular event (CVE) to establish the prevalence of Fabry disease. Details of this study have been published previously [8] . The study was approved by the Ethics committees at the leading center and each study site. All patients or their legal representatives gave written informed consent. Inclusion criteria were CVE <3 months, age 18-55 years, and cerebral MRI obtained within ≤ 1 month of inclusion. Diagnostic procedures were in accordance with the European Stroke Organisation Guidelines [9] .
A secondary aim of the sifap1 study was to better characterize the pattern of stroke in young patients collecting a broad range of clinical, laboratory, and radiological data using mandatory stringent standardized methods. The present secondary analysis aimed to investigate clinically relevant depressive symptoms (CRDS) and potential determinants such as demographics, risk factors, stroke severity, and imaging findings. CRDS were assessed on inclusion in the study with the Beck Depression Inventory (BDI).
Baseline Characteristics
A transient ischemic attack (TIA) was defined as a CVE with clinical symptoms lasting <24 h. Ischemic stroke subtypes were classified according to the published criteria in the Trial of Org 10172 in Acute Stroke Treatment (TOAST) [10] . Using information from medical history and concomitant medications we considered the following risk factors: diabetes, arterial hypertension, dyslipidemia, and cardiovascular disease (history of coronary artery, peripheral arterial or congestive heart disease, prior myocardial infarction, and/or valvular disease). Hypertension and dyslipidemia were defined according to national guidelines used at each study center. Anthropometric measurements (height, body weight in kilogram) obtained at study inclusion were used to calculate obesity according to body mass index (BMI ≥ 30). Details of further lifestyle risk factors were based on patients' self-report and standardized questionnaires. Tobacco use was considered in the case of those who were currently smoking or those who had quit smoking in the last 5 years. Regular drinking was defined as a consumption of at least one drink/week; higher consumption referred to more than five drinks a day at least once a month. Severity of stroke (NIHSS) was assessed within the first 48 h or at the time of maximal impairment. Short night sleep duration was defined as sleeping ≤ 6 at night time per 24 h. Physical inactivity was defined as walking less than 1 mile per day. Demographics (age, sex, and ethnicity) were included in the mandatory core data set collected by centers.
Beck Depression Inventory
The BDI is a 21-question multiple-choice self-reported questionnaire to measure the degree of depressive symptoms [11] . Each item has a set of four potential answer options, ranging in intensity. The score ranges from 0 to 63; scores of 18 or higher indicate CRDS [2, 11] . The assessment was performed on inclusion in the study and was an optional procedure.
Cerebral Magnetic Resonance Imaging (MRI)
Cerebral MRI was mandatory for all study participants. Standardized MRI sequences were required by protocol (at least T2-weighted and/or fluid-attenuated inversion recovery images and diffusion-weighted imaging sequences) [12] . All MR images were analyzed offline centrally by experienced readers blinded to clinical and demographic data (C.E., F.F., R.S.). For ischemic infarcts they noted infarct type and number, infarct location, size, and vascular territories involved by using the templates by Tatu et al. [12] . DWI sequences served to identify areas of acute ischemia [12, 13] . Old infarcts were defined as areas of T2 hyperintensity with associated focal atrophy and/or containing fluid-filled spaces [12] . White matter hyperintensities (WMHs) were defined as lesions with high signal intensity on T2-weighted images in the absence of evidence for complete tissue destruction and were ratTanislav et al. [12] . Deep WMHs were classified as 0 = absent, 1 = punctuate, 2 = early confluent, and 3 = confluent; periventricular white matter hyperintensities (PWMH) were stratified into: 0 = absent; 1 = pencil-thin lining; 2 = halo of ≥ 5 mm thickness; 3 = irregular WMH extending into deep white matter [12] . The total number and location of microbleeds (defined on gradient-echo T2 * -weighted images as areas of signal loss within the brain parenchyma not exceeding 5 mm in diameter) were recorded [12] . 
Statistical Analyses
Results
We obtained a BDI in 2007 from a total of 5,023 patients; 1,832 patients had an ischemic stroke or TIA and 100 patients had a primary hemorrhage; in 36 patients no stroke entity was documented, in further 39 other causes for stroke (e.g., cerebral vein thrombosis) were found. The comparison of patients with a BDI assessment versus those without a BDI assessment revealed no relevant differences in the proportions of diabetes and hypertension; patients with a BDI assessment were slightly younger (median 46 vs. 47 years, p = 0.031) and were less severely affected (NIHSS median 2 vs. 3, p = 0.001). Furthermore, a BDI assessment was obtained more often in patients with TIA, and less often in those with primary intracerebral hemorrhage and ischemic stroke ( table 1 ) .
The BDI score for the investigated population ranged from 0 to 47 (interquartile range: 1-11) with a median of five. The median delay for the BDI assessment was five days after admission (interquartile range 1-11 days). Overall, CRDS were present in 202 patients (10.1%); they occurred more often in female than in male patients (12.6 vs. 8.2%, p < 0.001). With increasing age, higher proportions of patients with CRDS were detected ( fig. 1 ).
While stroke severity was similar, patients with CRDS had more often arterial hypertension, diabetes mellitus, and dyslipidemia than patients without CRDS (hypertension: 58.0 vs. 47.1%, p = 0.017; diabetes mellitus: 17.9 vs. 8.9%, p < 0.001; dyslipidaemia: 40.5 vs. 32.3%, p = 0.012) ( table 2 ). In the subgroup of patients with ischemic stroke or TIA (n = 1,832), CRDS also occurred more frequently in females (11.8 vs. 8.3%, p = 0.014). The results of the analysis conducted within this group of patients (with stroke or TIA) is presented in tables 3 and 4 . In both sexes, those with CRDS had more often a CVE caused by large artery * Current smoking or quit within last 5 years. ** Cardiovascular disease considers one of the following conditions: ischemic coronary artery disease, myocardial infarctions, peripheral artery occlusive disease, congestive heart failure and valvular disease.
† Consumption of at least one drink/week. ‡ 5 drinks a day at least once a month. BDI = Beck depression inventory; IQR = interquartile range; TIA = transient ischaemic attack; NIHSS = National Institute of Health Stroke Scale. In the logistic regression analysis after adjusting for other relevant covariates female sex (OR 1.81, 95% CI 1.32-2.49) and diabetes mellitus (OR 2.04, 95% CI 1.46-2.86) were associated with CRDS ( table 5 ) .
Discussion
In this specific group of acute young strokes (18-55 years), we found 10.1% harboring CRDS in the early stage of their disease. The occurrence of CRDS was associated with the female sex and the presence of diabetes mellitus. Stroke severity and brain MRI lesion characteristics did not affect the occurrence of CRDS.
To view our results in an appropriate context and compare them with other investigations on depression in the acute phase of stroke, different aspects need to be considered: studies investigating mood disorders included patients mainly without age restriction and the definitions of disorders, instruments and the time intervals for the assessment differed widely [14] . In the sifap1 study depressiveness was assessed in the early stage of stroke (median 5 days after admission). For comparison few investigations in acute hospitalized strokes are available. In such studies relevant depressive symptoms were reported in 12-14% of the patients [15] [16] [17] . Hence, the rate of CRDS depicted in sifap1 (10.1%) is comparable to these results especially when considering that we examined a cohort of young strokes.
It needs to be considered, however, that a substantial proportion of patients seem to develop CRDS beyond the acute phase. In the FINNSTROKE study, BDI-values >18 were found in 24% of the patients at three months after the CVE; one year later the proportion rose to 30%. The obviously small proportion of depressed stroke patients in the acute stage and the high depression incidence within the first year render specific therapeutic measurements necessary, with potential benefit in avoiding this complication. Especially in young stroke, this approach deserves more attention in the rehabilitation process. Positive effects in recovery could be expected, allowing potentially quicker social and occupational reintegration and in particular the restart of professional activities.
In our study, females with acute stroke suffered more often from CRDS than males. This finding was also depicted in previous studies conducted in general stroke populations [2, [18] [19] [20] . As an explanation, the authors speculated that many stroke patients are older women living alone [2, 19, 20] . In sifap1 young stroke patients were recruited; thus, our results cannot be explained by loneliness of older women. Other mechanisms such as genetic predisposition, fluctuating hormone levels in women or direct psychological issues such as coping with traumatic events appear to be more relevant [21] [22] [23] . Facing the high psychological impact related to a CVE, sexspecific coping strategies could be relevant for explaining sex differences regarding CRDS in our patients. The tendency for developing depressive symptoms after stroke more often in older ages could also be observed in our study [18] . In both sexes, the oldest age group of 45-55 years exhibited the largest proportion of patients with CRDS.
The relationship between WMH and mood disorders is contradictory. While some authors suggest WMH may play a role in the development of mood disorders, others report no association between WMH and depressive symptoms [24] [25] [26] [27] [28] [29] . When dealing with stroke patients, no relation between post-stroke depressive symptoms and pre-existing WMH in the brain could be ascertained [26, 29, 30 ] . An association of WMH and delayed mood disorders after stroke has been described, but no relevance for the development of depressive symptoms in the acute stage [16, 30] has been found . Accordingly, our findings are in line with these findings; in our study, WMH (at all or stratified by severity) were not associated with the occurrence of CRDS. Acute ischemic lesions were also not associated with CRDS, in contrast to investigations claiming a relevance of lesion's location such as the affected region [26, 30] . Overall, our findings suggest that in young stroke patients, depressive symptoms in the acute stage are rather related to a psychological reactive phenomenon to the event itself than to pre-existing or acute lesions of the brain. Scarce evidence exists indicating the association of vascular risk factors with the occurrence of depression after stroke [25, 31] . The multiple logistic regression analysis in the subgroup of patients with ischemic stroke or TIA showed that apart from sex diabetes mellitus there remained an independent parameter associated with CRDS after controlling for other relevant characteristics. In this context, stroke subtypes favored by vascular risk factors did not emerge as independent factors. The reasons for the association of diabetes mellitus and depression after stroke remain unclear, albeit differences in cognitive performance could play a role. This hypothesis arises from recent studies showing that diabetes might independently determine cognitive decline in vascular patients [32] .
In our study, depressive symptoms were investigated with a validated standard tool for assessing CRDS, but no cognition assessments were provided. This is one of the main limitations of the present investigation; in several investigations, the cognitive status featured as a main determinant for depressive symptoms irrespective of current circumstances. A further limitation represents the lack of a direct control group for comparison. Sifap1 was designed for establishing the prevalence of Fabry disease in an unselected population of young stroke patients; thus a cross-sectional investigation was the appropriate choice. However, data derived from case control studies suggest that CRDS in young healthy individuals are less frequent than in sifap1 [33] [34] [35] [36] . As the BDI-assessment was an optional item within the study, it was not done in all study participants. In this context, the selection bias of exclusion of patients more severely affected by stroke form BDI assessment needs to be considered when interpreting our results, whereas there was no such bias with regard to sex. The BDI is a self-reporting assessment for investigating depressive symptoms. Even validated for the utilization in this manner, a verification of the diagnosis in a direct consultation or examination by specialists was not allocated. This might represent another limitation especially among patients with low scores in the BDI assessment.
Conclusion
In summary, we detected CRDS in 10.1% of young acute stroke patients early after the event. Parameters such as characteristics of acute lesions or the presence of WMH were not associated with the presence of CRDS. Diabetes mellitus was the most important parameter associated with CRDS. In female patients, CRDS occurred more often as compared to male individuals, probably due to different strategies in coping with traumatic events. Further investigations in young strokes are required to prove the long-term follow up of CRDS. This is especially of interest for the development of tailored treatment strategies for the rehabilitation, potentially beneficial for the recovery process.
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